Active, not recruitingPhase 1NCT03389230

Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

Studying Giant cell glioblastoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
City of Hope Medical Center
Principal Investigator
Behnam Badie, MD
City of Hope Medical Center
Intervention
HER2(EQ)BBζ/CD19t+ T cells(biological)
Enrollment
29 enrolled
Eligibility
18-75 years · All sexes
Timeline
20182026

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03389230 on ClinicalTrials.gov

Other trials for Giant cell glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Giant cell glioblastoma

← Back to all trials